Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-13-003773
Filing Date
2013-04-01
Accepted
2013-04-01 14:24:23
Documents
13
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K tlon_10k-123112.htm 10-K 2000339
2 EXHIBIT 10.41 ex10-41.htm EX-10.41 21143
3 EXHIBIT 23.1 ex23-1.htm EX-23.1 4669
4 EXHIBIT 31.1 ex31-1.htm EX-31.1 16317
5 EXHIBIT 31.2 ex31-2.htm EX-31.2 16314
6 EXHIBIT 32.1 ex32-1.htm EX-32.1 8356
13 img1.jpg GRAPHIC 32809
  Complete submission text file 0001437749-13-003773.txt   10882550

Data Files

Seq Description Document Type Size
7 tlon-20121231.xml EX-101.INS 1794713
8 tlon-20121231.xsd EX-101.SCH 85894
9 tlon-20121231_cal.xml EX-101.CAL 37394
10 tlon-20121231_def.xml EX-101.DEF 435892
11 tlon-20121231_lab.xml EX-101.LAB 570462
12 tlon-20121231_pre.xml EX-101.PRE 440625
Mailing Address 2207 BRIDGEPOINTE PARKWAY SUITE 250 SAN MATEO CA 94404
Business Address 2207 BRIDGEPOINTE PARKWAY SUITE 250 SAN MATEO CA 94404 650-588-6404
Talon Therapeutics, Inc. (Filer) CIK: 0001140028 (see all company filings)

EIN.: 320064979 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-32626 | Film No.: 13730425
SIC: 2834 Pharmaceutical Preparations